What is Eli Lilly's current stock price?

The stock price was $1,213.91 as of July 2, 2026.

What drove Eli Lilly's stock surge?

The surge was driven by strong sales of diabetes and obesity drugs, new regulatory approvals, and investor confidence.

How does Eli Lilly's performance compare to other pharma companies?

Eli Lilly has outperformed most other big pharma names in growth over the past year.

Eli Lilly Adds $400B in Market Value in One Year

Eli Lilly (LLY) added approximately $400 billion in market value over the past year, with shares rising 56.86% from $773.86 to $1,213.91. The drugmaker's market capitalization now stands at $1.063 trillion, reshaping the big pharma landscape.

July 9, 2026

2 min read

Source: 24/7 Wall St.

Key Numbers

market cap added

400B

previous price

773.86

current price

1213.91

percentage gain

56.86%

market cap

1.063T

Eli Lilly (NYSE:LLY) has added roughly $400 billion to its market value over the past year, with shares climbing from $773.86 on July 2, 2025 to $1,213.91 on July 2, 2026, a gain of 56.86%. This pushed the drugmaker's market capitalization to $1.063 trillion, making it the fastest-growing major pharmaceutical company.

Reasons for the Surge

The rally is driven by several factors:

Strong drug sales: Success of blockbuster drugs like Mounjaro and Zepbound for diabetes and obesity.
Regulatory approvals: New indications and approvals expanding the addressable market.
Investor confidence: Positive outlook on future revenue growth and pipeline strength.

Sector Context

While Eli Lilly leads the pack, other big pharma names like Pfizer and Merck have struggled to match its growth. This divergence is reshaping the competitive dynamics within the healthcare sector.

What It Means for Investors

This surge highlights Eli Lilly's strong position in the pharmaceutical industry, but investors should be mindful of high valuations and potential volatility. Monitoring upcoming earnings reports will be key to assessing whether the growth trajectory is sustainable.

Frequently Asked Questions

Eli Lilly's market cap reached $1.063 trillion after adding $400 billion.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.